SYNOPSIS A case is described in which a circulating anticoagulant, inhibiting antihaemophilic globulin, developed following temporal arteritis. The circulating anticoagulant disappeared with steroid therapy, reappearing when steroids were withdrawn. Permanent maintenance therapy appears necessary in this case to prevent haemorrhagic manifestations.
Five types of circulating anticoagulant have been described. The least common are heparin and heparin-like substances (Bell, 1951; Speer, Hill, Maloney, and Roberts, 1955; Quick and Hussey, 1957; Cetengil, Ulutin, and Karaca, 1959) . Such anticoagulants are readily identified by the fact that they are neutralized in vitro by protamine sulphate or toluidine blue. A more frequently encountered type is that which occurs in association with systemic lupus erythematosus (Conley and Hartmann, 1952; Bonnin, Cohen, and Hicks, 1956;  Medal and Lisker, 1959) . It is present in 10 (Frick, 1955) to 16 % (Lee, Sanders, and Kahny, 1955) of patients with systemic lupus and is usually associated with false positive reactions for syphilis and a positive cephalin flocculation test. It appears to retard the conversion of prothrombin to thrombin and does not often produce an overt haemorrhagic tendency. A third type, interfering with thrombin generation, has been observed in association with cryoglobulins, macroglobulins, and other abnormalities of the plasma proteins in such conditions as bacterial endocarditis (Mueller, Ratnoff, and Heinle, 1951) and myelomatosis (Andre, Dreyfus, Jacob, and Ley, 1952; Bernard, Inceman, Zara, and Christol, 1952 (Munro, 1946; Munro and Munro, 1946; Lamy, Burstein, and Soulier, 1946; Craddock and Lawrence, 1947; Soulier and Burstein, 1948; Conley, Rathbun, Morse, and Robinson, 1948; Tzanck, Soulier, and Blatrix, 1949; Van Creveld, Hoorweg, and Paulssen, 1951, 1953; Verstraete and Vandenbroucke, 1956) . One quarter have developed a circulating anticoagulant within a year of parturition (Fantl and Nance, 1946; Conley, Ratnoff, Ellicott, and Hartmann, 1950; O'Brien, 1953; Frick, 1953) , and some of these have persisted for many years. In one instance (Frick, 1953) the newborn child had the same circulating anticoagulant as the mother for the first 10 weeks of life but it caused no symptoms. In the remainder of the fifth group the circulating anticoagulant was found in others ise healthy adults, usually of mature years (Pons and de Torregrosa, 1952; Hougie, 1953; Verstraete and Vandenbroucke, 1956 ) or in association with a variety of conditions such as tuberculous lymphadenopathy (Lozner, Jolliffe, and Taylor, 1940) , reactive lymph node hyperplasia (Conley et al., 1948) , chronic nephritis and syphilis (Conley et al., 1948) , pemphigus (Quick and Stefanini, 1948; Dieter, Spooner, and Pohle, 1949) , dermatitis herpetiformis (Tzanck et al., 1949) , myocardial infarction (Singer, Mond, Hyman, and Levy, 1950) , rheumatoid arthritis (Collins and Ferriman, 1952) , rheumatic heart disease (Hardisty, 1954) , tonsillitis (Nussey and Dawson, 1957) , and ankylosing spondylitis (Douglas, 1958 (Table I) , and using the method of Biggs and Bidwell (1959) this was shown to be an antihaemophilic globulin inhibitor (Table II) .
The patient was readmitted to hospital as an emergency on 19 September 1960 (Fig. 1) 'The residual antihaemophilic globulin, assayed after incubation for one hour of patient's aluminium hydroxide-treated plasma and porcine antihaemophilic globulin, was 1 % of the residual antihaemophilic globulin ass yed after incubation for one hour of a haemophilic aluminium hydroxide-treated plasma and the same amount of porcine antihaemophilic globulin. (Cooke, Cloake, Govan, and Colbeck, 1946; Harrison, 1948; Ross Russell, 1959; Paulley and Hughes, 1960 (Medal and Lisker, 1959) , or the clotting time has been reduced (Conley and Hartmann, 1952; Bonnin, Cohen, and Hicks, 1956) . Patients with heparin-like anticoagulants have also shown a diminution in clotting time (Quick and Hussey, 1957) . Circulating anticoagulants interfering with the formation of thromboplastin have usually been unaffected by steroids. Those occurring in much transfused haemophiliacs have been unresponsive (Singer et al., 1950) or the patients have shown some diminution in clotting time (Van Creveld et al., 1953) ; those developing after pregnancy have been unaffected (Frick, 1953) ; and those seen in otherwise healthy individuals (Hougie, 1953; Verstraete and Vandenbroucke, 1956 ) and in association with other diseases (Collins and Ferriman, 1952; Douglas, 1958) have not altered. The case here reported is therefore unique in that a circulating anticoagulant interfering with the formation of thromboplastin by inhibiting antil-1(i. 1.
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